FDA issued Emergency Use Authorization for potential COVID-19 treatment
On May 1, 2020, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir…
USC study showed Alzheimer’s gene triggers early breakdowns in the blood-brain barrier, predicting cognitive decline
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
CDC launched the National Healthcare Safety Network COVID-19 Module Data Dashboard
On May 1, 2020, the CDC launched the National Healthcare Safety Network (NHSN) COVID-19 Module Data Dashboard showing…
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
CDC launched national viral genomics consortium to better map SARS-CoV-2 transmission
On May 1, 2020, the CDC launched the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance…
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
CHF Solutions shipped Aquadex product to COVID-19 specialty center in Minnesota
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
Cancer patients face high mortality from COVID-19
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
Athersys and University Hospitals Cleveland Medical Center announce activation of first clinical site for MACOVIA study for COVID-19 Induced ARDS
On May 1, 2020, Athersys and University Hospitals Cleveland Medical Center (UH Cleveland) announced that UH Cleveland is…
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors had been identified that can support the Company’s…
Evotec Biologics announced collaboration with Ology Bioservices on antibodies against Coronavirus
On Apr. 30, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics hasd entered into a…
FDA included ventilator developed by NASA in ventilator Emergency Use Authorization
On Apr. 30, 2020, the FDA included, under the ventilator emergency use authorization (EUA), a ventilator developed by…
Mesoblast began enrollment in phase 2/3 clinical trial of remestemcel-L in 300 patients with acute respiratory distress syndrome
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
AstraZeneca and Oxford University announced landmark agreement for COVID-19 vaccine
On Apr. 30, 2020, AstraZeneca and the University of Oxford announced an agreement for the global development and…
Oxford University announced a landmark partnership for development of COVID-19 vaccine
On Apr. 30, 2020, University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for…
Fujifilm Diosynth teamed with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity for COVID-19 therapies
On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for…
NIH’s axing of bat coronavirus grant a ‘horrible precedent’ and might break rules, critics say
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
Landmark partnership announced for development of COVID-19 vaccine
On Apr. 30, 2020, the University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca…
City of Hope began CIRM-funded Coronavirus study
On Apr. 30, 2020, The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hopeﾒs John…
Vaxart announced additional positive pre-clinical data for oral COVID-19 vaccine program
On Apr. 30, 2020, Vaxart announced it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
Mateon announced peer reviewed publication on its R&D effort against COVID-19
On Apr. 30, 2020, Mateon Therapeutics reported several peer-reviewed publications derived from its R&D effort against COVID-19. Published…
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
Nature publication presents new ‘Blueprint’ revealed how SARS-CoV-2 virus hijacks human cells
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
Biotechnology | COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics
Emory University launched study on COVID-19 immune responses
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
INOVIO expanded manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
NIH mobilized national innovation initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new $1.5 billion federal stimulus funding initiative aimed to speed…
NIH clinical trial shows remdesivir accelerated recovery from advanced COVID-19
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
The US Dept. of Veterans Affairs joined XPRIZE Pandemic Alliance to combat COVID-19 and future outbreaks
On Apr. 29, 2020, the U.S. Dep. of Veterans Affairs (VA) announced a partnership with the XPRIZE Foundationﾒs…
NIH mobilized national innovation RADx initiative for COVID-19 diagnostics
On Apr. 29, 2020, the NIH announced a new initiative aimed at speeding innovation, development and commercialization of…
Gilead announced results from phase 3 trial of investigational antiviral Remdesivir in patients with severe COVID-19
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…